Santen Pharmaceutical Co., Ltd. (SNPHF)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
As of 11:42AM EDT. Market open.
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 3.77B |
| Enterprise Value | 3.16B |
| Trailing P/E | 22.43 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.98 |
| Price/Book (mrq) | 1.93 |
| Enterprise Value/Revenue | 1.61 |
| Enterprise Value/EBITDA | 9.61 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 0.26 |
| 52-Week Change 3 | 15.87% |
| S&P500 52-Week Change 3 | 26.36% |
| 52 Week High 3 | 10.60 |
| 52 Week Low 3 | 8.46 |
| 50-Day Moving Average 3 | 9.59 |
| 200-Day Moving Average 3 | 9.44 |
Share Statistics
| Avg Vol (3 month) 3 | 87 |
| Avg Vol (10 day) 3 | 390 |
| Shares Outstanding 5 | 363.21M |
| Implied Shares Outstanding 6 | 363.84M |
| Float 8 | 348.92M |
| % Held by Insiders 1 | 2.79% |
| % Held by Institutions 1 | 50.92% |
| Shares Short 4 | N/A |
| Short Ratio 4 | N/A |
| Short % of Float 4 | N/A |
| Short % of Shares Outstanding 4 | N/A |
| Shares Short (prior month ) 4 | N/A |
Dividends & Splits
| Forward Annual Dividend Rate 4 | 0.22 |
| Forward Annual Dividend Yield 4 | 2.11% |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | 2.09 |
| Payout Ratio 4 | 45.60% |
| Dividend Date 3 | Jun 27, 2018 |
| Ex-Dividend Date 4 | Sept 27, 2024 |
| Last Split Factor 2 | 5:1 |
| Last Split Date 3 | Mar 27, 2015 |
Financial Highlights
Currency in JPY.Fiscal Year
| Fiscal Year Ends | Mar 31, 2024 |
| Most Recent Quarter (mrq) | Mar 31, 2024 |
Profitability
| Profit Margin | 8.82% |
| Operating Margin (ttm) | 3.01% |
Management Effectiveness
| Return on Assets (ttm) | 5.62% |
| Return on Equity (ttm) | 8.92% |
Income Statement
| Revenue (ttm) | 301.96B |
| Revenue Per Share (ttm) | 823.04 |
| Quarterly Revenue Growth (yoy) | -0.20% |
| Gross Profit (ttm) | N/A |
| EBITDA | 56.72B |
| Net Income Avi to Common (ttm) | 26.64B |
| Diluted EPS (ttm) | 0.46 |
| Quarterly Earnings Growth (yoy) | -97.40% |
Balance Sheet
| Total Cash (mrq) | 94.96B |
| Total Cash Per Share (mrq) | 261.62 |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 2.55 |
| Book Value Per Share (mrq) | 843.19 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 72.65B |
| Levered Free Cash Flow (ttm) | 50.53B |
© 2024 Yahoo. All rights reserved.